Bayer AG (BAYRY) and Atara Biotherapeutics (ATRA) have inked an exclusive worldwide license agreement for next-generation, mesothelin-directed CAR-T cell therapies for the treatment of solid ...

Atara Biotherapeutics Inc said on Friday that enrolment in an early-stage study of its experimental cancer therapy had been paused after a patient died, sending shares of the drug developer down 12%.